miR-93/miR-106b/miR-375-CIC-CRABP1: a novel regulatory axis in prostate cancer progression
Citations Over TimeTop 10% of 2015 papers
Abstract
Capicua (CIC) has been implicated in pathogenesis of spinocerebellar ataxia type-1 (SCA1) neurodegenerative disease and some types of cancer; however, the role of CIC in prostate cancer remains unknown. Here we show that CIC suppresses prostate cancer progression. CIC expression was markedly decreased in human prostatic carcinoma. CIC overexpression suppressed prostate cancer cell proliferation, invasion, and migration, whereas CIC RNAi exerted opposite effects. We found that knock-down of CIC derepresses expression of ETV5 and CRABP1 in LNCaP and PC-3 cells, respectively, thereby promoting cell proliferation and invasion. We also discovered that miR-93, miR-106b, and miR-375, which are known to be frequently overexpressed in prostate cancer patients, cooperatively down-regulate CIC levels to promote cancer progression. Altogether, we suggest miR-93/miR-106b/miR-375-CIC-CRABP1 as a novel key regulatory axis in prostate cancer progression.
Related Papers
- → Characterization of a novel metastatic prostate cancer cell line of LNCaP origin(2015)28 cited
- → Use of a hormone-sensitive (LNCaP) and a hormone-resistant (LNCaP-r) cell line in prostate cancer research(1997)20 cited
- → Development of a New Approach for the Therapy of Prostate Cancer with SPOP Mutations(2015)3 cited
- Inhibitive effect of androgen receptor antisense RNA on tumorigenesis of human prostate cancer cell LNCaP(2003)
- Establishment of androgen-independent human prostate cancer cell line model LNCaP-AI(2008)